Cite
Oropharyngeal administration of colostrum for preventing necrotizing enterocolitis and late-onset sepsis in preterm infants with gestational age ≤ 32 weeks: a pilot single-center randomized controlled trial
MLA
xia ouyang, et al. “Oropharyngeal Administration of Colostrum for Preventing Necrotizing Enterocolitis and Late-Onset Sepsis in Preterm Infants with Gestational Age ≤ 32 Weeks: A Pilot Single-Center Randomized Controlled Trial.” International Breastfeeding Journal, vol. 16, no. 1, Aug. 2021, pp. 1–15. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b3fb15b5fad5312a621a7ce7a5572286&authtype=sso&custid=ns315887.
APA
xia ouyang, Yan-Hua Hu, qin lin, Wen-Long Xiu, Chang-Yi Yang, & Su-Su Mei. (2021). Oropharyngeal administration of colostrum for preventing necrotizing enterocolitis and late-onset sepsis in preterm infants with gestational age ≤ 32 weeks: a pilot single-center randomized controlled trial. International Breastfeeding Journal, 16(1), 1–15.
Chicago
xia ouyang, Yan-Hua Hu, qin lin, Wen-Long Xiu, Chang-Yi Yang, and Su-Su Mei. 2021. “Oropharyngeal Administration of Colostrum for Preventing Necrotizing Enterocolitis and Late-Onset Sepsis in Preterm Infants with Gestational Age ≤ 32 Weeks: A Pilot Single-Center Randomized Controlled Trial.” International Breastfeeding Journal 16 (1): 1–15. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi.dedup.....b3fb15b5fad5312a621a7ce7a5572286&authtype=sso&custid=ns315887.